PACIRA BIOSCIENCES, INC. Payments to Acquire Long-term Investments
PACIRA BIOSCIENCES, INC. (PCRX) reported Payments to Acquire Long-term Investments of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireLongtermInvestments · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. payments to acquire long-term investments for the quarter ending 2025-12-31 was $0.00.
- PACIRA BIOSCIENCES, INC. payments to acquire long-term investments for the quarter ending 2025-09-30 was $0.00.
- PACIRA BIOSCIENCES, INC. payments to acquire long-term investments for the quarter ending 2024-12-31 was $0.00.
- PACIRA BIOSCIENCES, INC. payments to acquire long-term investments for the quarter ending 2024-09-30 was $0.00.
- PACIRA BIOSCIENCES, INC. payments to acquire long-term investments for fiscal 2025 was $1.25M.
- PACIRA BIOSCIENCES, INC. payments to acquire long-term investments for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- PACIRA BIOSCIENCES, INC. payments to acquire long-term investments for fiscal 2023 was $6.76M, a 48.02% decline from fiscal 2022.
- PACIRA BIOSCIENCES, INC. payments to acquire long-term investments for fiscal 2022 was $13.00M, a 24.36% decline from fiscal 2021.
| Period end | Payments to Acquire Long-term Investments 1 month | Payments to Acquire Long-term Investments 3 month | Payments to Acquire Long-term Investments 6 month | Payments to Acquire Long-term Investments 9 month | Payments to Acquire Long-term Investments 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-04 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $1.25M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.25M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $1.25M 10-Q · filed 2026-08-04 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $2.76M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $2.76M derived: sum of 3 quarters · filed 2026-02-26 | $6.76M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $2.76M derived: sum of 2 quarters · filed 2024-11-06 | $6.76M 10-Q · filed 2024-11-06 | $6.76M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $2.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $6.76M 10-Q · filed 2024-07-30 | $6.76M derived: sum of 3 quarters · filed 2025-02-27 | $7.01M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $4.00M 10-Q · filed 2024-05-07 | $4.00M derived: sum of 2 quarters · filed 2025-02-27 | $4.25M derived: sum of 3 quarters · filed 2025-02-27 | $4.25M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $250.00K derived: sum of 2 quarters · filed 2025-02-27 | $250.00K derived: sum of 3 quarters · filed 2025-02-27 | $13.00M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $250.00K derived: sum of 2 quarters · filed 2023-11-02 | $13.00M 10-Q · filed 2023-11-02 | $13.00M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $12.75M 10-Q · filed 2023-08-02 | $12.75M derived: sum of 3 quarters · filed 2024-02-29 | $15.72M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $12.75M 10-Q · filed 2023-05-03 | $12.75M derived: sum of 2 quarters · filed 2024-02-29 | $15.72M derived: sum of 3 quarters · filed 2024-02-29 | $28.72M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.97M derived: sum of 2 quarters · filed 2024-02-29 | $15.97M derived: sum of 3 quarters · filed 2024-02-29 | $17.19M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $2.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $15.97M derived: sum of 2 quarters · filed 2022-11-03 | $17.19M 10-Q · filed 2022-11-03 | $18.35M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $14.22M 10-Q · filed 2022-08-03 | $15.38M derived: sum of 3 quarters · filed 2023-02-28 | $15.38M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $1.22M 10-Q · filed 2022-05-04 | $2.38M derived: sum of 2 quarters · filed 2023-02-28 | $2.38M derived: sum of 3 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.16M derived: sum of 2 quarters · filed 2023-02-28 | $1.16M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $0.00 10-Q · filed 2021-11-03 | |||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-03 | ||||
| 2019-12-31 | $1.62M 10-K · filed 2022-02-28 | ||||
| 2019-06-30 | $1.60M 10-K · filed 2020-02-21 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $0.00 10-Q · filed 2015-10-27 | |||
| 2015-06-30 | $0.00 10-Q · filed 2015-07-30 | ||||
| 2014-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $10.98M derived: sum of 2 quarters · filed 2015-10-27 | $24.46M 10-K · filed 2015-02-24 | ||
| 2014-09-30 | $10.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $24.46M 10-Q · filed 2015-10-27 | |||
| 2014-06-30 | $13.48M 10-Q · filed 2015-07-30 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | $0.00 10-K · filed 2015-02-24 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $0.00 10-Q · filed 2014-10-30 | |||
| 2013-06-30 | $0.00 10-Q · filed 2014-07-31 | ||||
| 2012-12-31 | $0.00 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |